Dallas, TX [Sept 5, 2024] -- Spark Biomedical, a global pioneer in wearable neurostimulation solutions, proudly announces the launch of Sparrow Link, a revolutionary research platform that marks a significant advance in the field of neurostimulation. Building on the success of the FDA-cleared Sparrow Ascent, Sparrow Link empowers researchers with unparalleled control and flexibility in their studies; creating a better way forward in healthcare innovation.
All the components of the complete Sparrow Link platform create an advanced toolkit for neurostimulation research.
Designed with Researchers in Mind
The Sparrow® Link research platform is designed to help researchers forge a better way forward; arming them with ready-made tools that
A Better Way Forward in Medical Research
“Sparrow Link's robust API architecture offers researchers unprecedented control and flexibility,” says Dr. Alejandro Covalin, Ph.D., Chief Technology Officer at Spark Biomedical. “It enables seamless integration of our technology into diverse experimental protocols. This level of customization is poised to accelerate the pace of discovery in non-invasive auricular neurostimulation, opening new avenues for groundbreaking research across multiple disciplines.”
With the launch of Sparrow Link, Spark Biomedical invites the U.S. research community to join in pushing the boundaries of what’s achievable with transcutaneous auricular neurostimulation, propelling us all toward a future where collective innovation leads to transformative healthcare solutions.
Wondering if there's a better way to help patients overcome opioid withdrawal? Download the clinical trial whitepaper to learn more.